Gene therapy for inherited retinal diseases
- HQ
- Durham
- Sector
- biotech
- Stage
- series_c
- Total raised
- $150M
- Last round
- series_c
Founder profiles, enrichment notes, funding history, and investor connections are available to signed-in members.
Sign in to view full record